Osteoporosis Trial, Recruiting (NCT06525688)

Osteoporosis Trial, Recruiting NCT06525688 Sponsor: National and Kapodistrian University of Athens Condition: Osteoporosis

Printed from Voxsanity (voxsanity.com.au) — NCT06525688 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Osteoporosis

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

Postmenopausal women who have had a hip fracture (specifically a type called a subcapital femoral neck fracture) caused by osteoporosis (Arm 1)
Postmenopausal women who have hip osteoarthritis and are scheduled to have a total hip replacement surgery (Arm 2)

Who may not be able to join:

Patients who have previously had a bone fracture caused by osteoporosis before the current one
Patients who have serious heart, lung, immune system, or urinary system health conditions

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 26 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Efstathios Chronopoulos, KAT General Hospital, Athens Greece

Phone: 00306944837793

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06525688

Sponsor: National and Kapodistrian University of Athens

Phase: Not Applicable

Status: Recruiting

Condition: Osteoporosis

Trial contact: 00306944837793

More information: https://clinicaltrials.gov/study/NCT06525688

Eligibility summary (AI generated)

Written by an AI model from the ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

Postmenopausal women who have had a hip fracture (specifically a type called a subcapital femoral neck fracture) caused by osteoporosis (Arm 1)
Postmenopausal women who have hip osteoarthritis and are scheduled to have a total hip replacement surgery (Arm 2)

Who may not be able to join:

Patients who have previously had a bone fracture caused by osteoporosis before the current one
Patients who have serious heart, lung, immune system, or urinary system health conditions

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 26 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

National and Kapodistrian University of Athens

Registry

ClinicalTrials.gov

Start date

3 July 2024

Est. completion

15 October 2024

Where this trial is recruiting

🇬🇷 Greece

Primary endpoints

Identification of Proteomic Biomarkers; Identification of Metabolomic Biomarkers

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov